Does elective percutaneous coronary intervention (PCI) make sense for patients with stable coronary artery disease (CAD), or are some better off with optimal medical therapy? The answer may depend on our ability to document ischemia in these patients, but it also leads us to another question: are we doing enough, through stress testing or other means, to substantiate the need for PCI? Dr. Rita Redberg, professor of clinical medicine in the division of cardiology at the University of California, San Francisco, School of Medicine, talks with Dr. Janet Wright about the work-up and evaluation of patients with stable CAD.
Stable Coronary Artery Disease: PCI Versus Medical Therapy

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Does elective percutaneous coronary intervention (PCI) make sense for patients with stable coronary artery disease (CAD), or are some better off with optimal medical therapy? The answer may depend on our ability to document ischemia in these patients, but it also leads us to another question: are we doing enough, through stress testing or other means, to substantiate the need for PCI? Dr. Rita Redberg, professor of clinical medicine in the division of cardiology at the University of California, San Francisco, School of Medicine, talks with Dr. Janet Wright about the work-up and evaluation of patients with stable CAD.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
Updates From the 7th World Symposium Task Force
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?